Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03900884
Title Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer (PALVEN)
Acronym PALVEN
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Royal Melbourne Hospital Melbourne Victoria 3052 Australia Details
Austin Health Melbourne Victoria 3084 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field